The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial
EuroIntervention 2014;10:449-457 published online ahead of print January 2014. DOI: 10.4244/EIJV10I4A78
Yuki Ishibashi1, MD, PhD; Yoshinobu Onuma1, MD; Takashi Muramatsu1, MD, PhD; Shimpei Nakatani1, MD; Javaid Iqbal1, MRCP, PhD; Hector M. Garcia-Garcia1, MD, PhD; Antonio L. Bartorelli2, MD; Robert Whitbourn3, MD; Alexander Abizaid4, MD, PhD; Patrick W. Serruys1, MD, PhD; on behalf of the ABSORB EXTEND Investigators
1. Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands; 2. Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy; 3. St Vincent’s Hospital, Fitzroy, Victoria, Australia; 4. Instituto de Cardiologia Dante Pazzanese,
Aims: Bioresorbable scaffolds are increasingly used in patients with coronary artery disease undergoing percutaneous coronary interventions. ABSORB EXTEND is an ongoing study that will re